CFI-400945 ("sharpshooter" drug)

Alexandra
Alexandra Member Posts: 1,308
in Ovarian Cancer #1

The drug, known for now as CFI-400945, is a new class of cancer agent that targets an PLK4 enzyme involved in some malignancies, among them some types of breast cancer and ovarian, colorectal, pancreatic and prostate cancers.

Phase 1 trial is to start in September.

http://www.thestar.com/life/health_wellness/2013/06/18/cancer_breakthrough_new_drug_to_prevent_cancer_growth.html

http://www.ctvnews.ca/health/canadian-researchers-develop-drug-they-hope-will-slow-cancer-growth-1.1330737

Comments

  • 2timothy1 7
    2timothy1 7 Member Posts: 345
    #2
    Sharp shooter

    Love the pic. Too cute! Thanks for researching and posting! We never know when one o these clinica trials will work for us:).

  • poopergirl14052
    poopergirl14052 Member Posts: 1,183 Member
    #3
    2timothy1 7 said:

    Sharp shooter

    Love the pic. Too cute! Thanks for researching and posting! We never know when one o these clinica trials will work for us:).

    You are a master

    2013-06-24@finding good info. Thank you..nothing  can hide from you!   You are soooo cute...vVal 

Discussion Boards